Importance of Payer/Clinician Agreement in Patient Treatment

EP: 1.The Impact of Multiple Sclerosis on Quality of Life

EP: 2.Increased Prevalence of MS in Various Patient Subpopulations

EP: 3.The Importance of Early Diagnosis and Treatment in Patients with MS

EP: 4.Future Directions in Health Equity for MS Treatment

EP: 5.Challenges to Equal Access in MS Treatment

EP: 6.Impact of Limited Care for Patients with Chronic Disease

EP: 7.Population Disparities in Health Equity and Managed Care

EP: 8.Implications of Treatment Affordability Issues

Now Viewing

EP: 9.Importance of Payer/Clinician Agreement in Patient Treatment

EP: 10. Practical Steps to Mitigating Health Iniquity

Multiple sclerosis can profoundly affect the lives of those who receive the diagnosis, and racial and ethnic minorities appear to experience unique challenges regarding disease characteristics and access to care. Among these groups, the disease course may be more active (14) and the MS manifestations more severe. (12) For Black patients, certain DMTs may be less effective. (22) Sometimes experiencing barriers to care related to health literacy, income or health insurance coverage, (10) these groups may benefit from increased management across the care continuum that ensures access to patient education, financial and other support resources, and treatment tailored to their unique disease course.